E

EpiBiologics

17 employees

EpiBiologics develops antibody-based targeted therapies against membrane and extracellular proteins.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Medical

Date founded

2022

Funding rounds raised

Total raised

$50M

from 3 investors over 3 rounds

E

EpiBiologics raised $50M on March 22, 2023

Investors: Polaris Partners, GV and Vivo Capital

FAQ